Myriad Genetics Inc (MYGN)
18.65
-0.27
(-1.43%)
USD |
NASDAQ |
Apr 17, 16:00
18.65
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Shareholders Equity (Quarterly): 783.20M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 783.20M |
September 30, 2023 | 683.40M |
June 30, 2023 | 735.20M |
March 31, 2023 | 835.20M |
December 31, 2022 | 885.80M |
September 30, 2022 | 916.60M |
June 30, 2022 | 947.40M |
March 31, 2022 | 950.10M |
December 31, 2021 | 967.80M |
September 30, 2021 | 968.60M |
June 30, 2021 | 902.50M |
March 31, 2021 | 875.20M |
September 30, 2020 | 909.30M |
June 30, 2020 | 918.20M |
March 31, 2020 | 967.20M |
December 31, 2019 | 1.077B |
September 30, 2019 | 1.074B |
June 30, 2019 | 1.089B |
March 31, 2019 | 1.082B |
December 31, 2018 | 1.064B |
September 30, 2018 | 1.102B |
June 30, 2018 | 966.10M |
March 31, 2018 | 948.30M |
December 31, 2017 | 914.20M |
September 30, 2017 | 870.90M |
Date | Value |
---|---|
June 30, 2017 | 768.40M |
March 31, 2017 | 748.20M |
December 31, 2016 | 732.90M |
September 30, 2016 | 735.50M |
June 30, 2016 | 748.10M |
March 31, 2016 | 770.20M |
December 31, 2015 | 770.80M |
September 30, 2015 | 687.10M |
June 30, 2015 | 662.10M |
March 31, 2015 | 668.90M |
December 31, 2014 | 694.24M |
September 30, 2014 | 712.15M |
June 30, 2014 | 719.00M |
March 31, 2014 | 722.24M |
December 31, 2013 | 675.97M |
September 30, 2013 | 690.27M |
June 30, 2013 | 728.59M |
March 31, 2013 | 664.93M |
December 31, 2012 | 662.12M |
September 30, 2012 | 635.57M |
June 30, 2012 | 635.66M |
March 31, 2012 | 652.19M |
December 31, 2011 | 616.76M |
September 30, 2011 | 578.99M |
June 30, 2011 | 566.79M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
683.40M
Minimum
Sep 2023
1.089B
Maximum
Jun 2019
915.91M
Average
917.40M
Median
Shareholders Equity (Quarterly) Benchmarks
Stryker Corp | 18.59B |
Haemonetics Corp | 943.32M |
Perspective Therapeutics Inc | 75.18M |
Electromed Inc | 40.34M |
Xtant Medical Holdings Inc | 51.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.146B |
Total Liabilities (Quarterly) | 363.30M |
Debt to Equity Ratio | 0.0492 |
Current Ratio | 2.012 |
Net Debt Paydown Yield | -0.45% |